Abreos gets Grant of 850 000 USD for monitoring of Crohns disease
/
DateFeb 25 2020
Abreos Biosciences has been awarded funding for phase two of the "Personalized precision dosing of anti-TNF biological therapies" project by, among others, the National Institute of Health's (NIH). This "Fast Track Award" is the second part of a project focused on treating chronic inflammatory diseases.
Read More →